Maarten L Janmaat

Years Active: 2020-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kristel Kemper, Ellis Gielen, Peter Boross, Mischa Houtkamp, Theo S Plantinga, Stefanie Ah de Poot, Saskia M Burm, Maarten L Janmaat, Louise A Koopman, Edward N van den Brink, Rik Rademaker, Dennis Verzijl, Patrick J Engelberts, David Satijn, A Kate Sasser, Esther C W Breij
Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life science alliance 5 (11) (2022)
Julia Boshuizen, Nora Pencheva, Oscar Krijgsman, Daniela D'Empaire Altimari, Patricia Garrido Castro, Beaunelle de Bruijn, Maarten A Ligtenberg, Elke Gresnigt-Van den Heuvel, David W Vredevoogd, Ji-Ying Song, Nils Visser, Georgi Apriamashvili, Maarten L Janmaat, Theo S Plantinga, Patrick Franken, Mischa Houtkamp, Andreas Lingnau, Maria Jure-Kunkel, Daniel S Peeper
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade. Cancer research 81 (7) (2021)
Aran F Labrijn, Maarten L Janmaat, Janice M Reichert, Paul W H I Parren
Bispecific antibodies: a mechanistic review of the pipeline. Nature reviews. Drug discovery 18 (8) (2020)

Maarten L Janmaat.css-eqlu8i{font-size:small;padding-left:4px;}